Haffkine Biopharmaceuticals

Executive Summary

Haffkine Bio-Pharmaceutical Corporation, a Government of Maharashtra undertaking, is a key manufacturer of essential vaccines and antisera for India's public health system. With over four decades of experience, the company produces life-saving products including the Oral Polio Vaccine (OPV), snake and scorpion antivenom, and other bacterial/viral vaccines. Its strong government backing and focus on affordable, traditional biologics position it as a critical supplier for national immunization programs. While not a high-growth biotech, Haffkine's stability and public health importance make it a resilient entity in the Indian pharmaceutical landscape.

Upcoming Catalysts (preview)

• Q2 2026Government contract renewal for OPV and antisera supply90% success
• Q4 2026Expansion of manufacturing capacity for antivenom70% success
• TBDCollaboration with global health organizations for new vaccine development40% success